Sections

Sections Burkholderia cepacia
Overview
Presentation
- History
- Physical
- Causes
- Complications
- Show All
DDx
Workup
Treatment
Medication
References

Overview

Background

Burkholderia cepacia is an aerobic gram-negative bacillus found in various aquatic environments. B cepacia is an organism of low virulence and is a frequent colonizer of fluids used in the hospital (eg, irrigation solutions, intravenous fluids). B cepacia rarely causes infection in healthy hosts. Based on phenotypic and genotypic analyses, B cepacia is divided into 9 genomovars that constitute the B cepacia complex (BCC).

Pathophysiology

B cepacia is almost always a colonizing organism rather than an infecting organism, but it may be important when isolated from body fluids that are ordinarily sterile. The pathophysiology of B cepacia infection mirrors that of other nonfermentative aerobic gram-negative bacilli.

Frequency

United States

B cepacia is ordinarily not a pathogen in the ambulatory setting, but it may colonize and/or infect the respiratory tract of patients with cystic fibrosis or bronchiectasis. B cepacia may also cause central venous catheter–related infections in patients with cancer and in those on hemodialysis. B cepacianosocomial pneumonia has rarely been reported, usually in patients treated with fluoroquinolones and ceftazidime. Skin and soft-tissue infections, surgical-wound infections, and genitourinary tract infections with B cepacia have also been reported.

According to the US Cystic Fibrosis Foundation’s 2016 National Patient Registry, 3% percent of all persons with cystic fibrosis were infected with B cepacia complex compared to 2.6% in 2012.^[1]

International

B cepacia is generally not a pathogen in the ambulatory setting, but it may colonize and/or infect the respiratory tract of patients with cystic fibrosis or bronchiectasis.

Mortality/Morbidity

If an intravenous infusate contains high numbers of B cepacia, direct injection into the bloodstream may result in gram-negative bacteremia.

Mortality and morbidity is highest in those with impaired pulmonary function (eg, cystic fibrosis, bronchiectasis, chronic granulomatosis disease).

Disease severity (defined by the Simplified Acute Physiology Score II) and age are independent predictors of mortality.^[2]

Malignancy and a higher SOFA score at onset of bacteremia are associated with high mortality rates.^[3]

Race

Burkholderia has no racial predisposition.

Age

Burkholderia has no age predisposition.

Prognosis

Signs and symptoms of B cepacia infections are related to the organ system involved and are indistinguishable from infections with other pathogens.

Clinical Presentation

Cystic Fibrosis Patient Registry, 2016 Annual Data Report. CFF Homepage Cystic Fibrosis Foundation. Available at https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2016-Patient-Registry-Annual-Data-Report.pdf.
Righi E, Girardis M, Marchegiano P, Venturelli C, Tagliazucchi S, Pecorari M, et al. Characteristics and outcome predictors of patients involved in an outbreak of Burkholderia cepacia complex. J Hosp Infect. 2013 Sep. 85 (1):73-5. [Medline].
Liao CH, Chang HT, Lai CC, Huang YT, Hsu MS, Liu CY, et al. Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit. Diagn Microbiol Infect Dis. 2011 Jun. 70 (2):260-6. [Medline].
Lucero CA, Cohen AL, Trevino I, Rupp AH, Harris M, Forkan-Kelly S, et al. Outbreak of Burkholderia cepacia complex among ventilated pediatric patients linked to hospital sinks. Am J Infect Control. 2011 Jun 9. [Medline].
Alvarez-Lerma F, Maull E, Terradas R, et al. Moisturizing body milk as a reservoir of Burkholderia cepacia: outbreak of nosocomial infection in a multidisciplinary intensive care unit. Crit Care. 2008. 12(1):R10. [Medline].
Noriega ER, Rubinstein E, Simberkoff MS, Rahal JJ. Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts. Am J Med. 1975 Jul. 59 (1):29-36. [Medline].
Speller DC. Pseudomonas cepacia endocarditis treated with co-trimoxazole and kanamycin. Br Heart J. 1973 Jan. 35 (1):47-8. [Medline].
Eser I, Altan T, Stahl JE, Aydin MD, Inan N, Kapran Z, et al. Two cases of Burkholderia cepacia endophthalmitis. Br J Ophthalmol. 2006 Sep. 90 (9):1211. [Medline].
Yilmaz T, Celik I, Cihangiroglu M, Yildirim S, Akbulut A. Burkholderia cepacia: An unusual cause of postoperative endophthalmitis. Asian J Ophthalmol :. 2006. 8:121-3.
Al Attia HM, Qureshi RA, El Hag IA. Skull osteomyelitis and multiple brain abscesses. Postgrad Med J. 2000 Feb. 76 (892):124. [Medline].
Balfour-Lynn IM, Ryley HC, Whitehead BF. Subdural empyema due to Burkholderia cepacia: an unusual complication after lung transplantation for cystic fibrosis. J R Soc Med. 1997. 90 Suppl 31:59-64. [Medline].
Hobson R, Gould I, Govan J. Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis media. Eur J Clin Microbiol Infect Dis. 1995 Oct. 14 (10):908-11. [Medline].
McGowan JE Jr. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Infect Control. 2006 Jun. 34 (5 Suppl 1):S29-37; discussion S64-73. [Medline].
Abe K, D'Angelo MT, Sunenshine R, et al. Outbreak of Burkholderia cepacia bloodstream infection at an outpatient hematology and oncology practice. Infect Control Hosp Epidemiol. 2007 Nov. 28(11):1311-3. [Medline].
Anderson RL, Vess RW, Panlilio AL, et al. Prolonged survival of Pseudomonas cepacia in commercially manufactured povidone-iodine. Appl Environ Microbiol. 1990 Nov. 56(11):3598-600. [Medline].
Antibiotic Essentials. Cunha BA. Antibiotic Essentials. 12th ed. Jones & Bartlett, Sudbury, MA: Physicians Press; 2013.
Bender JM, Rand TH, Ampofo K, Pavia AT, Schober M, Tebo A, et al. Family clusters of variant X-linked chronic granulomatous disease. Pediatr Infect Dis J. 2009 Jun. 28(6):529-33. [Medline].
Berkelman RL, Lewin S, Allen JR, et al. Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med. 1981 Jul. 95(1):32-6. [Medline].
Burdge DR, Noble MA, Campbell ME, et al. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clin Infect Dis. 1995 Feb. 20(2):445-8. [Medline].
Clode FE, Metherell LA, Pitt TL. Nosocomial Acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med. 1999 Jul. 160(1):374-5. [Medline].
Conly JM, Klass L, Larson L, et al. Pseudomonas cepacia colonization and infection in intensive care units. CMAJ. 1986 Feb 15. 134(4):363-6. [Medline].
Coutinho CP, Dos Santos SC, Madeira A, Mira NP, Moreira AS, Sá-Correia I. Long-Term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations. Front Cell Infect Microbiol. 2011. 1:12. [Medline]. [Full Text].
Craven DE, Moody B, Connolly MG, et al. Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med. 1981 Sep 10. 305(11):621-3. [Medline].
Cunha CB, Cunha BA. Pseudoinfections and pseudo-outbreaks. Mayhall CG, ed. Hospital Epidemiology and Infection Control. 4th ed. Lippincott Williams & Wilkins; 2004.
De Boeck K, Malfroot A, Van Schil L, et al. Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients. Eur Respir J. 2004 Jun. 23(6):851-6. [Medline].
Duan X, Ling F, Zhou L, et al. Pacemaker generator pocket infection due to Burkholderia cepacia. J Hosp Infect. 2007 Dec. 67(4):392-3. [Medline].
Estivariz CF, Bhatti LI, Pati R, Jensen B, Arduino MJ, Jernigan D, et al. An outbreak of Burkholderia cepacia associated with contamination of albuterol and nasal spray. Chest. 2006 Nov. 130(5):1346-53. [Medline].
Ewig S, Welte T, Torres A. Is healthcare-associated pneumonia a distinct entity needing specific therapy?. Curr Opin Infect Dis. 2012 Apr. 25(2):166-75. [Medline].
Gilardi GL. Infrequently encountered Pseudomonas species causing infection in humans. Ann Intern Med. 1972 Aug. 77(2):211-5. [Medline].
Guide SV, Stock F, Gill VJ, Anderson VL, Malech HL, Gallin JI, et al. Reinfection, rather than persistent infection, in patients with chronic granulomatous disease. J Infect Dis. 2003 Mar 1. 187(5):845-53. [Medline].
Henderson DK, Baptiste R, Parrillo J, et al. Indolent epidemic of Pseudomonas cepacia bacteremia and pseudobacteremia in an intensive care unit traced to a contaminated blood gas analyzer. Am J Med. 1988 Jan. 84(1):75-81. [Medline].
Hutchinson J, Runge W, Mulvey M, et al. Burkholderia cepacia infections associated with intrinsically contaminated ultrasound gel: the role of microbial degradation of parabens. Infect Control Hosp Epidemiol. 2004 Apr. 25(4):291-6. [Medline].
Jones AM, Stanbridge TN, Isalska BJ, et al. Burkholderia gladioli: recurrent abscesses in a patient with cystic fibrosis. J Infect. 2001 Jan. 42(1):69-71. [Medline].
Lambiase A, Raia V, Stefani S, et al. Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis. J Microbiol. 2007 Jun. 45(3):275-9. [Medline].
Lee CS, Lee HB, Cho YG, et al. Hospital-acquired Burkholderia cepacia infection related to contaminated benzalkonium chloride. J Hosp Infect. 2008 Mar. 68(3):280-2. [Medline].
Leitão JH, Sousa SA, Cunha MV, Salgado MJ, Melo-Cristino J, Barreto MC, et al. Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center. Eur J Clin Microbiol Infect Dis. 2008 Nov. 27(11):1101-11. [Medline].
Liao CH, Chang HT, Lai CC, Huang YT, Hsu MS, Liu CY, et al. Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit. Diagn Microbiol Infect Dis. 2011 Jun. 70(2):260-6. [Medline].
Lipuma JJ, Marks-Austin KA, Holsclaw DS, et al. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J. 1994 Aug. 13(8):716-9. [Medline].
Lopez A, Amaro R, Polverino E. Does health care associated pneumonia really exist?. Eur J Intern Med. 2012 Jul. 23(5):407-11. [Medline].
Lucero CA, Cohen AL, Trevino I, Rupp AH, Harris M, Forkan-Kelly S, et al. Outbreak of Burkholderia cepacia complex among ventilated pediatric patients linked to hospital sinks. Am J Infect Control. 2011 Nov. 39(9):775-8. [Medline].
Mahenthiralingam E, Vandamme P. Taxonomy and pathogenesis of the Burkholderia cepacia complex. Chron Respir Dis. 2005. 2(4):209-17. [Medline].
Martin M, Christiansen B, Caspari G, Hogardt M, von Thomsen AJ, Ott E, et al. Hospital-wide outbreak of Burkholderia contaminans caused by prefabricated moist washcloths. J Hosp Infect. 2011 Mar. 77(3):267-70. [Medline].
Martin M, Winterfeld I, Kramme E, Ewert I, Sedemund-Adib B, Mattner F. [Outbreak of Burkholderia cepacia complex caused by contaminated alcohol-free mouthwash]. Anaesthesist. 2012 Jan. 61(1):25-9. [Medline].
Martone WJ, Osterman CA, Fisher KA, et al. Pseudomonas cepacia: implications and control of epidemic nosocomial colonization. Rev Infect Dis. 1981 Jul-Aug. 3(4):708-15. [Medline].
McMenamin JD, Zaccone TM, Coenye T, et al. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest. 2000 Jun. 117(6):1661-5. [Medline].
Nasser RM, Rahi AC, Haddad MF, et al. Outbreak of Burkholderia cepacia bacteremia traced to contaminated hospital water used for dilution of an alcohol skin antiseptic. Infect Control Hosp Epidemiol. 2004 Mar. 25(3):231-9. [Medline].
Pallent LJ, Hugo WB, Grant DJ, et al. Pseudomonas cepacia as contaminant and infective agent. J Hosp Infect. 1983 Mar. 4(1):9-13. [Medline].
Panlilio AL, Beck-Sague CM, Siegel JD, et al. Infections and pseudoinfections due to povidone-iodine solution contaminated with Pseudomonas cepacia. Clin Infect Dis. 1992 May. 14(5):1078-83. [Medline].
Rosenstein BJ, Hall DE. Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis. Johns Hopkins Med J. 1980 Nov. 147(5):188-9. [Medline].
Rutala WA, Weber DJ, Thomann CA, et al. An outbreak of Pseudomonas cepacia bacteremia associated with a contaminated intra-aortic balloon pump. J Thorac Cardiovasc Surg. 1988 Jul. 96(1):157-61. [Medline].
Schaffner W, Reisig G, Verrall RA. Outbreak of Pseudomonas cepacia infection due to contaminated anaesthetics. Lancet. 1973 May 12. 1(7811):1050-1. [Medline].
Sobel JD, Hashman N, Reinherz G, Merzbach D. Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med. 1982 Aug. 73(2):183-6. [Medline].
Speller DC, Stephens ME, Viant AC. Hospital infection by Pseudomonas cepacia. Lancet. 1971 Apr 17. 1(7703):798-9. [Medline].
St Denis M, Ramotar K, Vandemheen K, et al. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis. Chest. 2007 Apr. 131(4):1188-96. [Medline].
Steere AC, Tenney JH, Mackel DC, et al. Pseudomonas species bacteremia caused by contaminated normal human serum albumin. J Infect Dis. 1977 May. 135(5):729-35. [Medline].
Tablan OC, Martone WJ, Jarvis WR. The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis. Eur J Epidemiol. 1987 Dec. 3(4):336-42. [Medline].
van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS One. 2009. 4(4):e5234. [Medline]. [Full Text].
Weems JJ. Nosocomial outbreak of Pseudomonas cepacia associated with contamination of reusable electronic ventilator temperature probes. Infect Control Hosp Epidemiol. 1993 Oct. 14(10):583-6. [Medline].
Wilson JA, Viggars S, Parsons A. Pseudomonas cepacia pseudobacteraemia associated with a contaminated blood gas analyzer. J Hosp Infect. 1987 Nov. 10(3):314-5. [Medline].
Yamagishi Y, Fujita J, Takigawa K, et al. Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients. Chest. 1993 Jun. 103(6):1706-9. [Medline].
Zainal Abidin I, Syed Tamin S, Huat Tan L, et al. Pacemaker infection secondary to burkholderia pseudomallei. Pacing Clin Electrophysiol. 2007 Nov. 30(11):1420-2. [Medline].
Ángeles-Garay U, Zacate-Palacios Y, López-Herrera JR, Hernández-Sánchez EA, Silva-Sánchez J, Ascencio-Montiel Ide J. [Hospital outbreak of urinary tract infections by lubricant gel contaminated with Burkholderia cepacia]. Rev Med Inst Mex Seguro Soc. 2012 Nov-Dec. 50(6):615-22. [Medline].

Media Gallery

of 0

Author

Syed Faisal Mahmood, MBBS Associate Professor of Infectious Diseases, Program Director, Infectious Diseases Fellowship Program, Department of Medicine, Aga Khan University Hospital, Pakistan

Disclosure: Nothing to disclose.

Coauthor(s)

Sara Ahmed, MBBS, FCPS Fellow in Adult Infectious Diseases, Aga Khan University Hospital, Pakistan

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Richard B Brown, MD, FACP Chief, Division of Infectious Diseases, Baystate Medical Center; Professor, Department of Internal Medicine, Tufts University School of Medicine

Richard B Brown, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Chest Physicians, American College of Physicians, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, Massachusetts Medical Society

Disclosure: Nothing to disclose.

Chief Editor

Michael Stuart Bronze, MD David Ross Boyd Professor and Chairman, Department of Medicine, Stewart G Wolf Endowed Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center; Master of the American College of Physicians; Fellow, Infectious Diseases Society of America; Fellow of the Royal College of Physicians, London

Michael Stuart Bronze, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Medical Association, Association of Professors of Medicine, Infectious Diseases Society of America, Oklahoma State Medical Association, Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

Additional Contributors

Burke A Cunha, MD Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Charles S Levy, MD Associate Professor, Department of Medicine, Section of Infectious Disease, George Washington University School of Medicine

Charles S Levy, MD is a member of the following medical societies: American College of Physicians, Infectious Diseases Society of America, Medical Society of the District of Columbia

Disclosure: Nothing to disclose.

Sections Burkholderia cepacia
Overview
Presentation
- History
- Physical
- Causes
- Complications
- Show All
DDx
Workup
Treatment
Medication
References

Burkholderia cepacia

Background

Pathophysiology

Epidemiology

Frequency

Mortality/Morbidity

Race

Age

Prognosis

References

Tables

Contributor Information and Disclosures

What would you like to print?